Therapeutics

Marea Therapeutics Launches with $190 Million to Transform Cardiometabolic Disease Treatment

June 20, 2024

Tectonic Therapeutic Appoints Daniel Lochner as CFO

June 5, 2024

Summit Therapeutics Receives $200M Investment and Expands Ivonescimab License Territories

June 5, 2024

Electra Therapeutics Announces Key Executive Appointments to Advance Antibody Therapy Development

June 5, 2024

Virtual Therapeutics and Akili, Inc. Enter Definitive Merger Agreement

May 30, 2024

Progentos Therapeutics Secures $65 Million Series A to Advance MS Treatment

May 22, 2024

ADDF Invests $5M in Coya Therapeutics for FTD Phase 2 Trial

May 22, 2024

Enlaza Therapeutics Secures $100M in Series A Funding

May 1, 2024

Andrew Kidd Appointed CEO of Tentarix Biotherapeutics

April 25, 2024

Xaira Therapeutics Launches with $1 Billion to Innovate Drug Discovery

April 25, 2024